Twitter LinkedIn
    Wednesday, July 6
    Login
    0 Shopping Cart
    Twitter LinkedIn
    Private Equity InsiderPrivate Equity Insider
    • About Us
    • Digital Events
    • Our Network
      • Reach
      • Sponsors
      • Members
    Private Equity InsiderPrivate Equity Insider
    Home»Deals & Transactions»OMERS Private Equity Announces the Sale of Interest in Forefront Dermatology to Partners Group
    Deals & Transactions

    OMERS Private Equity Announces the Sale of Interest in Forefront Dermatology to Partners Group

    February 14, 20221 Min Read
    LinkedIn Facebook Twitter Email WhatsApp
    Share
    LinkedIn Facebook Twitter Email WhatsApp

    OMERS Private Equity today announced that it has signed an agreement to sell its interest in Forefront Dermatology to leading global private markets firm, Partners Group, acting on behalf of its clients. As part of the transaction, OMERS as well as Forefront’s physicians and executive team will reinvest in Forefront as minority owners. Located throughout the U.S. East, Midwest, Mid-Atlantic, Southwest, Southeast and West, Forefront Dermatology is the largest physician-led single specialty group providing dermatological services in the United States and comprises over 200 dermatology practices.

    With a strong focus on the healthcare segment, OMERS Private Equity’s portfolio of current and past investments in the space includes: Gastro Health, Community Veterinary Partners, CBI Health Group, Paradigm Outcomes, Premise Health, National Veterinary Associates, Accelerated Rehabilitation Centers, and Great Expressions Dental.

    The transaction is expected to close in early Q2 2022. Further financial terms will not be disclosed. OMERS and Forefront were advised by Harris Williams, Ernst & Young, Sidley Austin and McDermott Will & Emery.

    Read more: GlobeNewswire

    Related

    Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.

    deals and transactions PE Insider Private Equity
    Share. LinkedIn Facebook Twitter Email WhatsApp

    Related Posts

    Clearlake Capital and Motive Partners complete acquisition of BETA+ from LSEG

    July 5, 2022

    Biosynth Carbosynth acquires KKR’s Pepscan

    July 5, 2022

    Triton to tap €5.2bn Fund V for OCU buyout

    July 5, 2022

    Private lenders are offering cheaper debt than Wall Street banks

    July 5, 2022

    Comments are closed.

    Other Articles

    IRISH TECH COMPANIES RAISE RECORD VENTURE CAPITAL FUNDING OF €392M IN SECOND QUARTER

    August 30, 2021

    SK Capital acquires Canlak and Valentus Specialty Chemicals

    June 2, 2021

    Verdane’s Desenio in largest Nordic e-commerce company listing on NASDAQ

    March 6, 2021

    Ardian’s Burghardt Believes in Deal in Veolia-Suez Standoff

    March 31, 2021

    Private Equity Insider LLC
    1212 Avenue of the Americas
    New York City 10036
    USA

    [email protected]

    Twitter LinkedIn
    © 2022 Private Equity Insider LLC. All rights reserved.
    • About
    • Terms of Use
    • Cookie Policy
    • Privacy Policy
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.

    View Cart Checkout Continue Shopping

    Sign In or Register

    Welcome Back!

    Login to your account below.

    Lost password?